Thirumalai Chemicals Credit Ratings Downgraded by ICRA

ICRA has downgraded the credit ratings for Thirumalai Chemicals Ltd (TCL), citing concerns over the company's liquidity and increased debt levels, primarily driven by a significant cost escalation in its US project.

What just happened

Long-term ratings for term loans, working capital, and non-convertible debentures were downgraded to [ICRA]BBB (Negative) from [ICRA]BBB+ (Negative). The short-term rating for non-fund based instruments was downgraded to [ICRA]A3+ from [ICRA]A2.

Why this matters

The downgrade signals increased financial risk for Thirumalai Chemicals. The company's reliance on additional debt to fund its US project will heighten its leverage and strain its liquidity, especially with significant debt repayments due from FY2027.

The backstory

The US project's cost has surged to USD 340 million from an initial USD 255 million. Operations commencement is now expected by December 2026, delayed from June/July 2026. This is attributed to higher construction costs, increased demand for skilled labor, greater interest expenses, and rising project management costs in the US.

What changes now

The company is expected to take on more debt to cover the project cost overrun. This increases financial leverage and puts pressure on the liquidity profile as debt repayments loom from FY2027.

Risks to watch

Thirumalai Chemicals breached financial covenants with lenders in FY2026, requiring waivers. Future covenant compliance and securing further waivers are critical. The company's 'stretched' liquidity position is a concern, with limited unencumbered cash against upcoming debt obligations.

Peer comparison

(No peer comparison data available in the filing).

Context metrics (time-bound)

• US project cost revised to USD 340 million (from USD 255 million).
• US project operations commencement extended to December 2026 (from June/July 2026).
• Operating profit in Q1FY2027 was Rs. 32.6 crore (up from Rs. 6.2 crore in Q4FY2026 and a loss of Rs. 26.7 crore in Q1FY2026).
• Unencumbered cash as of March 31, 2026: Rs. 63.99 crore.
• Principal repayment obligations: Rs. 169.92 crore (FY2027), Rs. 217.79 crore (FY2028).

What to track next

Investors should closely monitor Thirumalai Chemicals' ability to manage its debt-funded capital expenditure and its compliance with lender covenants. The successful execution and ramp-up of the US project without further delays or cost overruns are key.

Reader Takeaway: Credit rating downgrade highlights US project stress; operating profit recovery offers some relief.